Legal & General Group
ACH

Legal & General Group’s Accendra Health ACH Stock Holding History

Legal & General Group’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.6K Sell
6,893
-10,624
-61% -$33K ﹤0.01% 3051
2026
Q1 		$39.9K Hold
17,517
– – ﹤0.01% 2732
2025
Q4 		$49K Sell
17,517
-63,372
-78% -$227K ﹤0.01% 2731
2025
Q3 		$388K Sell
80,889
-132,635
-62% -$844K ﹤0.01% 2511
2025
Q2 		$1.94M Buy
213,524
+19,334
+10% +$142K ﹤0.01% 1971
2025
Q1 		$1.75M Sell
194,190
-17,871
-8% -$189K ﹤0.01% 1980
2024
Q4 		$2.77M Buy
212,061
+8,195
+4% +$109K ﹤0.01% 1845
2024
Q3 		$3.2M Sell
203,866
-187
-0.1% -$2.83K ﹤0.01% 1781
2024
Q2 		$2.75M Sell
204,053
-4,784
-2% -$98K ﹤0.01% 1797
2024
Q1 		$5.79M Buy
208,837
+75
+0% +$1.67K ﹤0.01% 1438
2023
Q4 		$4.02M Sell
208,762
-3,439
-2% -$62.3K ﹤0.01% 1631
2023
Q3 		$3.43M Sell
212,201
-4,784
-2% -$84.9K ﹤0.01% 1646
2023
Q2 		$4.13M Sell
216,985
-4,618
-2% -$82.4K ﹤0.01% 1571
2023
Q1 		$3.22M Sell
221,603
-6,057
-3% -$108K ﹤0.01% 1652
2022
Q4 		$4.45M Buy
227,660
+4,613
+2% +$90K ﹤0.01% 1461
2022
Q3 		$5.38M Sell
223,047
-895
-0.4% -$27.6K ﹤0.01% 1337
2022
Q2 		$7.04M Sell
223,942
-2,935
-1% -$106K ﹤0.01% 1253
2022
Q1 		$9.99M Buy
226,877
+3,161
+1% +$136K ﹤0.01% 1159
2021
Q4 		$9.73M Buy
223,716
+6,407
+3% +$251K ﹤0.01% 1218
2021
Q3 		$6.8M Buy
217,309
+34,341
+19% +$1.35M ﹤0.01% 1378
2021
Q2 		$7.75M Sell
182,968
-39,579
-18% -$1.54M ﹤0.01% 1313
2021
Q1 		$8.37M Buy
222,547
+19,723
+10% +$617K ﹤0.01% 1305
2020
Q4 		$5.49M Buy
202,824
+26,370
+15% +$678K ﹤0.01% 1419
2020
Q3 		$4.43M Buy
176,454
+2,413
+1% +$35.2K ﹤0.01% 1391
2020
Q2 		$1.33M Buy
174,041
+13,533
+8% +$99K ﹤0.01% 1893
2020
Q1 		$1.47M Buy
160,508
+1,181
+0.7% +$7.13K ﹤0.01% 1715
2019
Q4 		$824K Sell
159,327
-32,735
-17% -$210K ﹤0.01% 2113
2019
Q3 		$1.12M Sell
192,062
-56,052
-23% -$251K ﹤0.01% 1949
2019
Q2 		$794K Sell
248,114
-1,959
-0.8% -$6.68K ﹤0.01% 2025
2019
Q1 		$1.03M Buy
250,073
+40,007
+19% +$253K ﹤0.01% 1964
2018
Q4 		$1.33M Buy
210,066
+5,012
+2% +$52K ﹤0.01% 1787
2018
Q3 		$3.39M Buy
205,054
+15,863
+8% +$270K ﹤0.01% 1434
2018
Q2 		$3.18M Buy
189,191
+9,146
+5% +$148K ﹤0.01% 1410
2018
Q1 		$2.8M Buy
180,045
+71,387
+66% +$1.27M ﹤0.01% 1435
2017
Q4 		$2.05M Sell
108,658
-1,765
-2% -$39.1K ﹤0.01% 1611
2017
Q3 		$3.23M Buy
110,423
+8,331
+8% +$246K ﹤0.01% 1295
2017
Q2 		$3.29M Buy
102,092
+4,846
+5% +$159K ﹤0.01% 1229
2017
Q1 		$3.36M Buy
97,246
+13,009
+15% +$465K ﹤0.01% 1167
2016
Q4 		$2.98M Buy
84,237
+11,267
+15% +$381K ﹤0.01% 1150
2016
Q3 		$2.53M Buy
72,970
+10,031
+16% +$351K ﹤0.01% 937
2016
Q2 		$2.35M Buy
62,939
+7,482
+13% +$281K ﹤0.01% 903
2016
Q1 		$2.24M Sell
55,457
-12,172
-18% -$453K ﹤0.01% 881
2015
Q4 		$2.44M Sell
67,629
-1,049
-2% -$37.9K ﹤0.01% 895
2015
Q3 		$2.2M Sell
68,678
-2,072
-3% -$70.5K ﹤0.01% 900
2015
Q2 		$2.41M Buy
70,750
+2,482
+4% +$83.6K ﹤0.01% 890
2015
Q1 		$2.32M Buy
68,268
+15,045
+28% +$524K ﹤0.01% 881
2014
Q4 		$1.87M Sell
53,223
-1,005
-2% -$33.8K ﹤0.01% 901
2014
Q3 		$1.78M Buy
54,228
+14,233
+36% +$484K ﹤0.01% 889
2014
Q2 		$1.36M Buy
39,995
+12,400
+45% +$425K ﹤0.01% 935
2014
Q1 		$967K Buy
27,595
+1,159
+4% +$40.9K ﹤0.01% 987
2013
Q4 		$966K Buy
26,436
+2,158
+9% +$79.2K ﹤0.01% 973
2013
Q3 		$840K Hold
24,278
– – ﹤0.01% 993
2013
Q2 		$821K Buy
+24,278
New +$806K ﹤0.01% 921

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Legal & General Group's ACH Position: Q2 2026 in Review

Legal & General Group reduced its Accendra Health (ACH) stake by 61% in Q2 2026, selling an estimated $33K and leaving 6,893 shares worth $23.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3051.

Legal & General Group first reported a position in ACH in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.99M in Q1 2022. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Legal & General Group held 6,893 shares of Accendra Health worth $23.6K as of Q2 2026.
  • Legal & General Group sold 10,624 Accendra Health shares in Q2 2026, an estimated $33K.
  • Accendra Health made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3051 holding.
  • Legal & General Group first reported a position in Accendra Health in Q2 2013 and has held it in 53 quarters since.
  • Legal & General Group's Accendra Health position peaked at $9.99M in Q1 2022.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.